Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

FundamentalVR Fund Raise

31 May 2022 07:00

RNS Number : 3134N
Tern PLC
31 May 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

31 May 2022

 

Tern Plc

("Tern" or the "Company")

 

FundamentalVR Fund Raise

 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, is pleased to announce that FVRVS Limited ("FundamentalVR"), has undertaken a Series B fund raising round, securing £7 million in new equity investment (the "FundamentalVR Series B") from existing investors and a new institutional investor, at a valuation uplift of 77% from the previous book valuation of Tern's holding.

 

Highlights

 

· FundamentalVR has raised a total of £7 million in a Series B fund raising from existing investors and a new institutional investor, with an additional £1.2 million of convertible loan notes being converted

 

· Tern has converted approximately £570,000 in loan notes and accrued interest it held in FundamentalVR into equity, in line with the terms of these loan notes, but will invest no new money in the FundamentalVR Series B

 

· The FundamentalVR Series B is intended to provide FundamentalVR with funding to enable to grow in line with its strategy, including expanding its US activities

 

· With the completion of the £7 million FundamentalVR Series B, including the conversion of Tern's loan notes to equity, Tern will hold 20.0% of FundamentalVR's equity, valued at £6.3 million at the valuation implied by the FundamentalVR Series B price

 

FundamentalVR Fund Raise

 

Prior to the FundamentalVR Series B, Tern had a holding of 26.9% in FundamentalVR, plus a loan convertible into FundamentalVR equity of £530,000 and accrued interest of £39,932. As at 31 December 2021, the date of Tern's last published book valuation, this holding had an audited book value of £3.6 million. 

 

Following the FundamentalVR Series B funding of £7 million, the conversion of Tern's £0.53 million of loan notes and the conversion of £0.63 million of loan notes held by other investors, FundamentalVR is now valued in total at approximately £23 million on a pre-money basis and Tern now has a holding of 20.0% in FundamentalVR (before any dilution on exercise of any future FundamentalVR employee share options), with an unaudited book valuation of £6.3 million, representing a 77% uplift on the 31 December 2021 book value of Tern's holding.

 

Further information on FundamentalVR

 

FundamentalVR delivers virtual reality haptic 'flight simulators' for surgery creating a safe, measurable and repeatable space to refine skills. FundamentalVR's goal is to transform the way surgeons prepare, practice, and refine their skills. It has built an immersive, surgical simulation application platform, Fundamental Surgery, to provide medical professionals with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

According to the latest filed financial statements for FundamentalVR, for the 12 month period ended 31 December 2020, the business recorded an increase in retained unaudited losses of £2.12 million and at that date had unaudited net assets of approximately £1.27 million. Given the historic nature of these figures Tern does not consider this to be representative of the current business and trading performance of FundamentalVR.

 

Further information on FundamentalVR may be found at: https://www.fundamentalvr.com

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKKBDKBKBCPN
Date   Source Headline
10th Mar 20227:00 amRNSWyld Networks Purchase Orders
2nd Mar 20227:00 amRNSParticipation in SVV UK Software Technology Fund
22nd Feb 20223:09 pmRNSDevice Authority Agreement with Avnet
11th Feb 20227:00 amRNSPortfolio Update
1st Feb 20227:00 amRNSTalking Medicines Fund Raise
11th Jan 20221:45 pmRNSWyld Networks Connectivity Partnership
31st Dec 202112:30 pmRNSTotal Voting Rights
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Dec 202112:30 pmRNSChange in Wyld Networks Shareholding
20th Dec 20217:00 amRNSInVMA Fund Raise and Update
15th Dec 20213:04 pmRNSExercise of Options
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20219:00 amRNSPrice Monitoring Extension
2nd Dec 20214:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20214:35 pmRNSPrice Monitoring Extension
2nd Dec 20212:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 202110:01 amRNSDevice Authority Strategic Investment & Funding
1st Dec 20217:00 amRNSDevice Authority convertible loan notes
26th Oct 20217:00 amRNSPortfolio Update
20th Sep 20217:30 amRNSWyld purchase order from Bayer Crop Science
16th Sep 20217:00 amRNSInvestor webinar recording
14th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20214:35 pmRNSPrice Monitoring Extension
3rd Sep 20212:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20212:00 pmRNSPrice Monitoring Extension
3rd Sep 202111:05 amRNSSecond Price Monitoring Extn
3rd Sep 202111:00 amRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSWyld Networks Third Party Funding
17th Aug 20217:00 amRNSInvestment in FundamentalVR and Portfolio Update
4th Aug 20214:41 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20212:06 pmRNSSecond Price Monitoring Extn
4th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 20215:18 pmRNSTotal Voting Rights
14th Jul 20217:00 amRNSResult of Fundraise
13th Jul 20215:07 pmRNSRetail Offer
13th Jul 20215:05 pmRNSEquity Fundraise of up to £4 million
2nd Jul 20218:05 amRNSWyld Networks - Trading on NASDAQ First North
28th Jun 202110:00 amRNSWyld Networks IPO Update
25th Jun 20214:40 pmRNSSecond Price Monitoring Extn
25th Jun 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.